Downloads: 53
Research Paper | Medical Science | Volume 10 Issue 2, February 2021 | Pages: 1006 - 1008 | Indonesia
Central Nervous System Effect of Efavirenz at Wangaya Hospital 2017 - 2020
Abstract: Background: Efavirenz is commonly used of NNRTI that produces its antiretroviral activity by binding directly to the enzyme reverse transcriptase, thus inhibiting replication of the virus. One reason for that, efavirenz to cross the blood-brain barrier and can cause central nervous system (CNS) adverse effect. In addition, we have discussed the efavirenz CNS symptoms include dizziness, headache, insomnia, anxiety, vivid or abnormal dreams. Methodology: we conducted descriptive use medical record data from patient living with HIV/AIDS (PLWHA) with efavirenz theraphy at Wangaya Regional General Hospital in Bali, Indonesia during 2017-2020. We excluded PLWHA under age
Keywords: efavirenz, CNS, ART, descriptive
How to Cite?: Lisa Anggriani Susanto, I Made Bayu Surya Dana, Ketut Suryana, "Central Nervous System Effect of Efavirenz at Wangaya Hospital 2017 - 2020", Volume 10 Issue 2, February 2021, International Journal of Science and Research (IJSR), Pages: 1006-1008, https://www.ijsr.net/getabstract.php?paperid=SR21203224255, DOI: https://dx.doi.org/10.21275/SR21203224255